Compare PRPO & AIOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PRPO | AIOS |
|---|---|---|
| Founded | N/A | 2005 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Biotechnology: Laboratory Analytical Instruments | Metal Fabrications |
| Sector | Industrials | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 42.0M | 42.8M |
| IPO Year | 2000 | 2014 |
| Metric | PRPO | AIOS |
|---|---|---|
| Price | $29.44 | $16.00 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 97.5K | 28.2K |
| Earning Date | 05-12-2026 | 04-20-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 92.15 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $24,049,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 29.77 | N/A |
| 52 Week Low | $14.28 | $0.39 |
| 52 Week High | $33.63 | $33.87 |
| Indicator | PRPO | AIOS |
|---|---|---|
| Relative Strength Index (RSI) | 65.82 | 66.07 |
| Support Level | $21.45 | $10.58 |
| Resistance Level | $33.63 | $18.80 |
| Average True Range (ATR) | 2.14 | 1.73 |
| MACD | 0.53 | 0.38 |
| Stochastic Oscillator | 73.67 | 84.96 |
Precipio Inc is a healthcare biotechnology company focused on cancer diagnostics. Its objective is to enhance diagnostic accuracy & accessibility while building a sustainable business model that supports ongoing innovation. The company operates Clinical Laboratory Improvement Amendments laboratories in both New Haven, Connecticut, & Omaha, Nebraska, providing essential blood cancer diagnostics to office-based oncologists in many states nationwide. The company operates in a single segment, which includes two divisions: the Pathology Services Division & the Products Division. The Pathology Services provides specialized cancer diagnostic testing services. The pathology services division specializes in diagnostic testing focused mainly on hematologic cancers.
AIOS Tech Inc is a provider of artificial intelligence and technology-driven professional services. The Company is focused on delivering information technology solutions, data services, and artificial intelligence-powered offerings to a diverse commercial client base. Its core businesses include digital transformation services, tailored IT solutions for the financial sector, enterprise data solutions, and the development of AI platforms and infrastructure to drive efficiency and growth for clients across multiple industries.